NAMPT/NAD + /PARP1 Pathway Regulates CFA‐Induced Inflammatory Pain via NF‐κB Signaling in Rodents
Advanced Biology · 2024
DOI: 10.1002/adbi.202400028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, 2024. Verfasst von Yi Dai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310009, China. Hauptthemen laut MEDLINE: Nicotinamide Phosphoribosyltransferase, Ganglia, Spinal, NAD, Poly (ADP-Ribose) Polymerase-1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Zhejiang Provincial Natural Science Foundation of China, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Emerging evidence has implicated nicotinamide adenine dinucleotide (NAD + ) metabolism in various inflammatory diseases. In the study, the role of NAD + metabolism in Complete Freund's Adjuvant (CFA)‐evoked inflammatory pain and the underlying mechanisms are investigated. The study demonstrated that CFA induced upregulation of nicotinamide phosphoribosyltransferase (NAMPT) in dorsal root ganglia (DRG) without significant changes in the spinal cord. Inhibition of NAMPT expression by intrathecal injection of NAMPT siRNA alleviated CFA‐induced pain‐like behavior, decreased NAD + contents in DRG, and lowered poly‐(ADP‐ribose) polymerase 1 (PARP1) activity levels. These effects are all reversed by the supplement of nicotinamide mononucleotide (NMN). Inhibition of PARP1 expression by intrathecal injection of PARP1 siRNA alleviated CFA‐induced pain‐like behavior, while elevated NAD + levels of DRG. The analgesic effect of inhibiting NAMPT/NAD + /PARP1 axis can be attributed to the downregulation of the NF‐κB/IL‐1β inflammatory pathway. Double immunofluorescence staining showed that the expression of NAMPT/NAD + /PARP1 axis is restricted to DRG neurons. In conclusion, PARP1 activation in response to CFA stimulation, fueled by NAMPT‐derived NAD + , mediates CFA‐induced inflammatory pain through NF‐κB/IL‐1β inflammatory pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310009, China.
- East Hospital Affiliated to Tongji University, Shanghai, 200000, China.
- Lishui Municipal Central Hospital, Lishui, 323000, China.
ORCID-Profile: Lina Yu
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Dai, Y., Lin, J., Chen, X., Ren, J., Wu, C., Shen, H., Li, X., Yu, J., Jiang, B., & Yu, L. (2024). NAMPT/NAD + /PARP1 Pathway Regulates CFA‐Induced Inflammatory Pain via NF‐κB Signaling in Rodents. Advanced Biology. https://doi.org/10.1002/adbi.202400028
Vancouver
Dai Y, Lin J, Chen X, Ren J, Wu C, Shen H, et al. NAMPT/NAD + /PARP1 Pathway Regulates CFA‐Induced Inflammatory Pain via NF‐κB Signaling in Rodents. Advanced Biology. 2024. doi:10.1002/adbi.202400028
BibTeX
@article{Dai2024,
author = {Dai, Yi and Lin, Jiaqi and Chen, Xiangde and Ren, Jinxuan and Wu, Chengwei and Shen, Huihui and Li, Xue and Yu, Jing and Jiang, Baochun and Yu, Lina},
title = {NAMPT/NAD + /PARP1 Pathway Regulates CFA‐Induced Inflammatory Pain via NF‐κB Signaling in Rodents},
journal = {Advanced Biology},
year = {2024},
doi = {10.1002/adbi.202400028}
}
EUVIMED